ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner, Family

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,381Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 279

$522K Total Retail Price of All Prescriptions

Rank: 12 out of 279

398 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

15% of this provider’s 398 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

3% of this provider’s 8,479 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $72 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 496 440 1 4
SIMVASTATIN 474 308 2 5
OMEPRAZOLE 391 300 3 7
LISINOPRIL 385 287 4 2
METFORMIN HCL 342 251 5 3
FUROSEMIDE 307 263 6 6
HYDROCHLOROTHIAZIDE 267 182 7 8
POTASSIUM CHLORIDE 228 169 8 15
HYDROCODONE-ACETAMINOPHEN 219 157 S3 9 10
FENOFIBRATE 205 157 10 73
AMLODIPINE BESYLATE 197 162 11 1
MELOXICAM 194 134 12 16
NEXIUM 184 128 13 13
PRAVASTATIN SODIUM 167 123 14 9
ZOLPIDEM TARTRATE 152 85 15 22
ATENOLOL 140 116 16 25
AMITRIPTYLINE HCL 139 110 R 17 42
GLIMEPIRIDE 134 102 18 19
ATORVASTATIN CALCIUM 133 110 19 17
TRIAMTERENE-HCTZ 118 106 20 77
AZITHROMYCIN 117 86 21 28
METOPROLOL TARTRATE 113 90 22 12
ALLOPURINOL 110 98 23 62
METFORMIN HCL ER 105 83 24 50
CRESTOR 102 85 25 23
SERTRALINE HCL 98 72 26 32
CLOPIDOGREL 95 74 27 27
WARFARIN SODIUM 94 80 28 21
CITALOPRAM HBR 94 88 28 33
FAMOTIDINE 90 66 30 106
METOPROLOL SUCCINATE 84 77 31 18
LOVASTATIN 83 79 32 40
LISINOPRIL-HYDROCHLOROTHIAZIDE 81 51 33 20
CIPROFLOXACIN HCL 80 73 34 51
BYSTOLIC 79 67 35 82
LANTUS 76 71 36 52
ADVAIR DISKUS 76 42 36 75
PROAIR HFA 71 18 38 53
SYNTHROID 68 57 39 34
DICLOFENAC POTASSIUM 67 50 40 194
INDAPAMIDE 66 66 41 197
CARVEDILOL 66 54 41 24
DIOVAN 66 33 41 37
GABAPENTIN 65 47 44 14
ESCITALOPRAM OXALATE 64 38 45 63
TAMSULOSIN HCL 64 59 45 57
TRAMADOL HCL 62 43 47 11
VOLTAREN 62 34 47 201
PREDNISONE 61 27 49 26
DONEPEZIL HCL 56 56 50 60
FLUCONAZOLE 54 26 51 162
DIOVAN HCT 53 32 52 36
PLAVIX 53 45 52 48
SPIRIVA 53 30 52 67
LOSARTAN POTASSIUM 52 36 55 31
NAMENDA 51 51 56 59
ALENDRONATE SODIUM 51 51 56 54
ESTRADIOL 50 47 R 58 102
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.